Clinical trials in Norway
5,654 studies list at least one site in Norway. 863 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.
Status
- Completed
- 3,445
- Recruiting
- 723
- Active, not recruiting
- 498
- Status unknown
- 403
- Terminated
- 372
- Enrolling by invitation
- 72
Phase
- Phase 3
- 1,190
- Phase 2
- 828
- Phase 4
- 366
- Phase 1
- 250
- Early Phase 1
- 15
Most studied here
Who runs them
Oslo University Hospital (746) · Norwegian University of Science and Technology (446) · Haukeland University Hospital (266) · St. Olavs Hospital (154) · University of Oslo (149) · Novartis Pharmaceuticals (143) · University Hospital of North Norway (141) · University of Bergen (118)
Studies
Recruiting first, then most recently updated. Showing 50 of 5,654 — search for more.
- Optical Coherence Tomography in Acute Vessel EvaluationEnrolling by invitationNCT07422688Not applicable
- Reestablishing Normal Gut-brain Interaction in Anorexia Nervose With Normal Gut MicrobiotaNot yet recruitingNCT07574892Phase 1
- A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)RecruitingNCT06136559Phase 3
- A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDPRecruitingNCT06920004Phase 3
- Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung CancerRecruitingNCT06890598Phase 3
- Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPERRecruitingNCT05640999Phase 2
- A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering DrugsRecruitingNCT05663515
- A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALLRecruitingNCT05748171Phase 2
- A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)RecruitingNCT07585266Phase 3
- Effects of Digital Detox on Mental Health in Young AdultsNot yet recruitingNCT07827703Not applicable
- PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm PreeclampsiaRecruitingNCT06033131Phase 3
- A Study of Pirtobrutinib in Participants With Immune ThrombocytopeniaRecruitingNCT06721013Phase 1/2
- Pan Tumor Rollover StudyRecruitingNCT03899155Phase 2
- Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-TrialRecruitingNCT03977571Not applicable
- (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic MastocytosisRecruitingNCT04910685Phase 2/3
- Thrombolysis in Factor Xa-inhibitors TrialRecruitingNCT06878066Phase 3
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRecruitingNCT07184931Phase 3
- A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP DeletionRecruitingNCT07063745Phase 2/3
- Daycase Hip and Knee Arthroplasty in Møre and Romsdal TrialNot yet recruitingNCT07834034
- A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney DiseaseRecruitingNCT05970172Phase 3
- A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)RecruitingNCT06290141Phase 3
- A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)RecruitingNCT04844606Phase 3
- Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)RecruitingNCT04924075Phase 2
- A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (GLOBALIGHT)RecruitingNCT06351605
- EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) TumorsRecruitingNCT07262619Phase 1/2
- Optimizing Patient Treatment With EPA-enriched Nutrition, a Randomised Control TrialRecruitingNCT07255066Not applicable
- A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and AdultsRecruitingNCT07222137Phase 3
- A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal AdenocarcinomaRecruitingNCT07522073Phase 3
- A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)RecruitingNCT07222332Phase 3
- Visugromab in Cachexia International TrialRecruitingNCT07112196Phase 2/3
- A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)RecruitingNCT07165028Phase 3
- Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)RecruitingNCT07100080Phase 2/3
- A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian CancerRecruitingNCT07213804Phase 3
- Biological Profiles of Neuropeptides, Neurotrophins and miRNA in MigraineNot yet recruitingNCT07832032
- Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their FamiliesRecruitingNCT05744310Not applicable
- A European Network for the Investigation of Gender IncongruenceRecruitingNCT01072825
- Stereotactic Ablative Radiotherapy for OligoMetastatic Breast CancerRecruitingNCT05377047Phase 3
- Effect of Patiromer in Children Under 12 Years of Age With High Blood Potassium LevelsRecruitingNCT05766839Phase 2
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)RecruitingNCT05485961Phase 2/3
- Mitral Valve Prolapse Arrhythmic RiskRecruitingNCT07830888
- Product Surveillance RegistryRecruitingNCT01524276
- A Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06722235Phase 3
- Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T CellsRecruitingNCT03435796Phase 2/3
- Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 StudiesRecruitingNCT05682378Phase 3
- Blue-blocking Glasses for Sleep Disorders in Child and Adolescent PsychiatryRecruitingNCT07433491Not applicable
- A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood TransfusionsRecruitingNCT07422480Phase 3
- Reduced-Dose Versus Full-Dose Alteplase for High-Risk Pulmonary EmbolismNot yet recruitingNCT07816978Phase 4
- Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)RecruitingNCT06393374Phase 3
- Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)RecruitingNCT03486873Phase 3
- A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerRecruitingNCT06340568Phase 3